Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.’s Net Profit Dropped 7.2% in First Three Quarters of 2023

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (南京健友生化制药股份有限公司) (603707.SH) reported a net profit of 839.3 million yuan in the first three quarters of 2023, down 7.2% year-on-year.

Meanwhile, the company posted 3.1 billion yuan in revenue, up 10.2% year-on-year.

At the end of the reporting period, it had 11.1 billion yuan in total assets and 4.3 billion yuan in total liabilities, with a liability-to-asset ratio of 38.6%.